Navigation Links
Experimental Vaccine Shows Promise for Ovarian Cancer
Date:4/7/2013

By Randy Dotinga
HealthDay Reporter

SATURDAY, April 6 (HealthDay News) -- A novel but preliminary new treatment for ovarian cancer has apparently produced complete remission for one patient with an advanced form of the disease, researchers are reporting.

The promising results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable disease at the end of the trial, the researchers added.

Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual meeting in Washington, D.C.

Ovarian cancer is fairly rare -- an estimated 1.38 percent of females born today will be diagnosed with the condition -- but it's an especially deadly form of cancer because it is usually diagnosed in an advanced stage.

The new treatment uses a personalized vaccine to try to teach the body's immune system how to fight off tumors.

Researchers took bits of tumor and blood from women with stage 3 or 4 ovarian cancer and created individualized vaccines, said study lead author Lana Kandalaft, director of clinical development and operations at the Ovarian Cancer Research Center in the University of Pennsylvania's Perelman School of Medicine.

"Each patient's tumor is unique like a fingerprint," she added. "We're trying to rewire the immune system to target the tumor."

Once the immune system has learned how to more effectively fight the cancer, the researchers isolate immune cells called dendritic cells, coax them to multiply, then put them back into the body to strengthen it.

The research is only in the first of three stages that are required before drugs can be sold in the United States. The first-phase studies aren't designed to determine if the drugs actually work, but are instead supposed to analyze whether they're safe.

This study, funded in part by the U.S. National Institutes of Health, found
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
2. Experimental Staph Vaccine Fails to Work, Study Finds
3. Experimental Drug May Work Against Hepatitis C
4. Experimental Alzheimers Drug Shows Promise, Study Finds
5. Experimental Vitiligo Treatment Shows Promise in Mice
6. Harmful effects of bisphenol A proved experimentally
7. Experimental agent briefly eases depression rapidly in test
8. NIH-funded trial launched to assess experimental TB drug
9. Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
10. Experimental Antidepressant Appears Quick-Acting, Safe
11. More than a third of high-risk leukemia patients respond to an experimental new drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Vaccine Shows Promise for Ovarian Cancer
(Date:9/18/2014)... proven it true: exercise is good for you. But ... exercise may have an added benefit for cancer patients ... model of melanoma, found that combining exercise with chemotherapy ... Libonati, an associate professor in the School of Nursing ... Nursing Research, was the senior author on the study, ...
(Date:9/18/2014)... NJ (PRWEB) September 18, 2014 ... firm, announced today that President and co-founder John ... Journal’s Innovation Award Winners for 2014, recognizing the ... him as an emerging executive of the year. ... care and life sciences that continue to shape ...
(Date:9/18/2014)... 2014 Ben Quirk, CEO of Quirk ... Leadership Award by the Savannah Science Seminar in recognition ... throughout the nation and especially in Savannah. , “I ... Ben. “The Savannah Science Seminar is an amazing program ... generations have gone through the program,” he added. Eleventh ...
(Date:9/18/2014)... international scientists have developed a new method to study ... , The Wildlife Conservation Society (WCS)-led research, published today ... describes the use of fecal samples from wild great ... to the virus. This represents a new tool for ... the way Ebola virus is studied and improve our ...
(Date:9/18/2014)... 2014) The National Institutes of Health (NIH) recently ... $1.3 million grant to the Los Angeles Biomedical Research ... development of a vaccine to protect patients from the ... aureus (MRSA). , The National Institute of ... the grant to LA BioMed infectious disease specialists John ...
Breaking Medicine News(10 mins):Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2
... joined hands today to boost efforts by governments in ... ,Headed by C Rangarajan, Chairman of the ... independent commission on AIDS in Asia and the Pacific ... of AIDS in the region and its medium- and ...
... an important ingredient in magic mushrooms is capable of ... addictions. ,Researchers at Johns Hopkins University ... element in mushrooms is capable of instilling a deep ... for those patients who have a huge psychological baggage ...
... about 1,500 medical professionals are available throughout the country ... in India // , President of Madras ENT Rearch ... ,Most of these professionals were concentrated in major ... said at a press conference prior to the inauguration ...
... reported in the United Kingdom, asthmatics will witness almost ... months of completely// staying off cigarettes. ... lung function seen after smoking cessation was clinically significant. ... the harmful effects of smoking on the airways in ...
... to invest more money in mental health, to bridge the ... , Although the new national mental health plan provided a ... short of the escalating expenditure, said John Mendoza, the chief ... ,Mr. Mendoza said that only 40 per cent ...
... the University of Vermont say that drinking cherry juice may ... number of antioxidant// and anti-inflammatory compounds that can deal with ... The British Journal of Sports Medicine, researchers said that men ... levels of inflammatory markers in their blood. The study examined ...
Cached Medicine News:
(Date:9/18/2014)... --  3D Systems   (NYSE: DDD ) announced ... a new robotic surgery skills and procedural training simulator, which ... exhibition in Amsterdam, The Netherlands from ... invasive surgery represents a growing portion of overall surgical volume, ... robotic surgery has increased, and it is expected that this ...
(Date:9/18/2014)... 18, 2014  Neurotrope, Inc. (OTCQB: NTRP) today announced ... Ph.D. to the Company,s Board of Directors, effective September ... vacancy on the Board of seven members. Dr. Altstiel ... Governance Committee and a member of the Audit and ... of Neurotrope,s Scientific Advisory Board, a position he has ...
(Date:9/18/2014)... Australian biomarker discovery company Minomic International Ltd will today ... cancer screening test, planning to achieve US Food and ... Minomic,s proprietary MiStat™ technology is a screening assay capable ... as the MIL-38 antigen. This biomarker is present on ... Researchers at 11 leading urology centres in ...
Breaking Medicine Technology:3D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 2Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 4Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... Pa., Jan. 12, 2011 ECRI Institute® ( ... the best approaches to improving patient care, is ... Health Devices Achievement Award program. The award ... technology management. (Logo: http://photos.prnewswire.com/prnh/20110112/DC29081LOGO ...
... 2011, what will be the major trends in the ... regulations affect what,s next and what,s new?  What will ... competitive corporate landscape?  When it comes to market research, ... the job done right? The answers to these questions ...
Cached Medicine Technology:ECRI Institute's 2011 Health Devices Achievement Award - Call for Entries 2ECRI Institute's 2011 Health Devices Achievement Award - Call for Entries 3Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event 2
The CryoSurgery console is the control center for CryoCath's surgical probe. It is a modular system made up of a console control unit and a tank dolly system. The system can be used as a unit or in s...
... developed a minimally invasive cryocatheter to ... delivers a very high level of ... site precision, minimal tissue disruption, and ... ,Freezor is a flexible, single-use, minimally ...
The Valve Mapper Steerocath-Dx has a unique "peanut" shaped tip. It is designed to conform to the anatomy during mapping procedures. Both 8F/8mm and 8F/6mm tips are available....
... The PORTERFIELD catheter incorporates six electrodes which ... from a single catheter. Positioned in the ... while recording atrial electrograms. The catheter may ... apex for atrial recording and ventricular pacing ...
Medicine Products: